Diaz Deborah

Director Diaz bought 1,050 shares of FRST at $12.77; stock now $12.85, -10.2% from 52-week high.

Director Deborah Diaz purchased 1,050 shares at $12.77 on 2026-03-06, increasing her holdings to 21,122 shares (+5.2%). Her cross-ticker track record shows 4 prior buys with an average 90-day return of -2.7% and a 50% win rate, indicating modest historical accuracy. At FRST specifically, she has a mixed record: one prior buy (2025-12-10) delivered +5.0% over 90 days, but two earlier buys (2024-12-12 and 2024-03-15) saw declines of -20.0% and -17.7% respectively, with only 1 of 3 prior trades well-timed at the 90-day mark. The current stock price of $12.85 is -10.2% from its 52-week high of $14.31, having declined -8.9% over the past 30 days, reflecting recent weakness. Additionally, the company reported full-year net income was negative despite showing $6.8M in the current period, and carries a high P/E of 36.71, signaling elevated valuation relative to earnings.

Director Diaz purchases 1,608 shares of FRST at $12.34; stock at 52-week high but prior FRST buys underperformed by 30d and 90d measures

Diaz Deborah, a director at Primis Financial, purchased 1,608 shares at $12.34 on 2025-12-10, bringing her holdings to 20,072 shares post-transaction. The stock has rallied 24.0% in the past 30 days and currently sits at its 52-week high of $13.38, suggesting strong recent momentum. However, this purchase follows a concerning pattern: her two prior open-market buys at FRST (2024-12-12 and 2024-03-15) resulted in negative 90-day returns of -20.0% and -17.7% respectively, with a 0% success rate in timing. Against this backdrop of prior missteps at the same ticker, the company's elevated P/E of 38.23 and reported unprofitability in its most recent full fiscal year warrant close attention to whether the recent price strength is supported by fundamentals.

Director Diaz buys 2,000 shares of FRST at $12.42; clusters with 3 other insider buys in 14 days; stock unprofitable over last full year.

Deborah Diaz purchased 2,000 shares at $12.42, increasing her holdings by 12.1% to 18,464 shares total. Three other insiders have also bought within the past 14 days, forming a cluster buy pattern. However, this activity follows material headwinds: the company was unprofitable over its most recent full fiscal year, and Diaz's sole prior trade at FRST on 2024-03-15 showed a 90-day return of -17.7%, indicating poor timing in that instance. The current stock price of $12.46 is -8.8% from its 52-week high, but absent explicit FLAGS indicating scheduled plans, the cluster of director purchases suggests internal interest in the stock at current levels despite the negative profitability backdrop.

Director Diaz bought 5,150 shares of ACHR at $7.48, increasing stake to 98,886 shares amid 90-day surge of +102.8%.

Deborah Diaz, a Director, purchased 5,150 shares at $7.48 on 2024-11-25, expanding her holdings from 93,736 to 98,886 shares. The transaction occurred near the 52-week high of $7.48, following a sharp 90-day price appreciation of +102.8% and a 30-day surge of +132.9%. However, this buy should be contextualized against Diaz's cross-ticker track record: across her prior open-market activity, she averaged a -17.7% 90-day return with a 0.00% win rate. Additionally, Archer Aviation itself remains unprofitable with a net income of $-115,300,000.00 over the most recent full fiscal year. The timing and magnitude of the purchase at a 52-week peak, combined with the insider's historical underperformance and the company's ongoing losses, present a profile that merits closer examination.

FRST director Diaz purchases 1,650 shares at $12.01 amid -$3.6M annual net loss.

Deborah Diaz, a director of Primis Financial Corp., purchased 1,650 shares at $12.01 on 2024-03-15, increasing her holdings from 14,814 shares to 16,464 shares. The purchase occurred while the company reported a full-year net income of -$3,567,000.00, indicating recent unprofitability. The stock currently trades at $12.07, approximately -11.7% from its 52-week high of $13.67, placing the transaction price near recent lows but above the 52-week floor of $7.63. The modest scale of the buy (1,650 shares, $19,811.55 total value) relative to her post-transaction holdings (16,464 shares) represents an 11.1% increase and does not by itself resolve the tension between the insider purchase and the company's negative earnings position.